Clinical Trial Update: Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal Function [Phase 1]

View source ↗

Summary

Phase 1 trial comparing a dose of telotristat etiprate in subjects with renal impairment to matched controls with normal renal function has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Impairment

Drugs mentioned

• Telotristat Etiprate (telotristat etiprate)

Snippet

Sponsor: Ipsen | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED | Results posted: 2019-09-13